Who is Heidi Overton?
Heidi Overton, MD, PhD, is President Trump's nominee to lead the FDA. A former Johns Hopkins surgery resident and White House Domestic Policy Council deputy director, she was nominated on August 19, 2026, with her Senate HELP Committee confirmation hearing held on September 24, 2026.
Why did Marty Makary resign as FDA commissioner?
Dr. Marty Makary resigned on May 12, 2026, reportedly under pressure after clashing with the White House over flavored tobacco product approvals. CBS News reported Makary was reluctant to approve fruit-flavored vapes against administration wishes.
What does Heidi Overton think about vaping?
As of her confirmation hearing, Heidi Overton had not publicly stated a detailed position on vaping or nicotine pouch regulation. Her policy direction on flavored e-cigarettes and PMTA processing is expected to emerge during and after the confirmation process.
How can I submit a public comment to the FDA about vaping?
You can submit public comments to the FDA through regulations.gov by searching for relevant FDA dockets. Comments can often be submitted anonymously. Focus on personal experience, data, and policy impacts rather than emotional arguments for greatest effect.
What is the FDA's May 2026 enforcement guidance?
Issued in May 2026, the FDA enforcement guidance allows most tobacco products to be sold legally after companies have filed applications but before they have received a complete scientific review. Public health groups including Campaign for Tobacco-Free Kids have sued over this guidance, arguing the FDA violated federal law by not providing public comment opportunity.
How many FDA-authorized vaping products are there?
As of September 2026, the FDA has authorized approximately 95 tobacco products from 11 companies, including 45 e-cigarette/vaping products, 30 nicotine pouch products, 10 heated tobacco products, 8 snus products, and 2 cigarette products.
Will Overton speed up or slow down vape approvals?
It is too early to predict with certainty. However, the Wall Street Journal reported on September 23, 2026, that the Trump administration plans to speed up authorization processes by revisiting 2021 rules and simplifying scientific study requirements. Overton will oversee implementation of these changes if confirmed.
What is the PMTA process?
PMTA (Premarket Tobacco Product Application) is the FDA process through which new tobacco products must demonstrate they are "appropriate for the protection of the public health" to receive marketing authorization. Congress mandated a review period of approximately six months, though in practice reviews have taken significantly longer. To learn more about the terminology, check our PMTA glossary entry.
